Skip to content
Disclosery

EXANE DERIVATIVES: HPQ position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on HPQ, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 722 HPQ shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 722 shares
    Change vs previous 13F -2 shares

    0.01% of the 13F portfolio, value $23,665.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 724 shares
    Change vs previous 13F -39 shares

    0.01% of the 13F portfolio, value $26,281.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 763 shares
    Change vs previous 13F +71 shares

    0.01% of the 13F portfolio, value $28,743.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 692 shares
    Change vs previous 13F -3,021 shares

    <0.01% of the 13F portfolio, value $18,934.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 3,713 shares
    Change vs previous 13F -11,891 shares

    0.02% of the 13F portfolio, value $104,671.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 15,604 shares
    Change vs previous 13F -7,434 shares

    0.15% of the 13F portfolio, value $495,446.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 23,038 shares
    Change vs previous 13F -30,453 shares

    0.17% of the 13F portfolio, value $566,525.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 53,491 shares
    Change vs previous 13F not available

    0.33% of the 13F portfolio, value $1,015,814.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).